EXOZYMES INC.
Income Statement
| Line Item | FY2023 |
|---|---|
| Revenue | $70.1K |
| Cost of Revenue | — |
| Gross Profit | — |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | $527.5K |
| SG&A Expense | $1.3M |
| Operating Income | $-1.8M |
| Operating Margin | -2,563.5% |
| Interest Expense | — |
| Pretax Income | $-2.0M |
| Income Tax Expense | $42.3K |
| Net Income | $-2.0M |
| Net Margin | -2,909.1% |
| EPS (Basic) | $-0.33 |
| EPS (Diluted) | $-0.33 |
| Shares Outstanding (Basic) | 6.3M |
| Shares Outstanding (Diluted) | 6.3M |
| Dividends Per Share | — |